Related Experiment Video
Updated: Feb 9, 2026
Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
Published on: April 25, 2017
MicroRNA-30 mediates cell invasion and metastasis in breast cancer
Shuangzhen Bao1, Xinying Wang2, Zhichao Wang3
1a General Surgery Department, Harrison International Peace Hospital, 180 Renmin Dong Road, Taocheng District, Hengshui 053000, Hebei, China.
Abstract:
Despite the great progress in recent years, many aspects of the pathogenesis and progression of breast cancer remain unclear. A better understanding on the molecular mechanisms underlying metastasis and recurrence is crucial to improve the treatment of this lethal disease. MCF-7 cells were xenografted into mice until visible tumors developed, and the cells from tumor tissue and adjacent normal tissue were cultured with 3 passages as mass tumor (MT) cells and invasive tumor (IT) cells, respectively. Microarray analysis was performed to detect several viable microRNAs in these 2 types of cells. Further, miR-30 knockdown was used to investigate its role in tumor aggression. Relative levels of miR-30 were significantly higher in IT cells than MT cells. Knockdown of miR-30 in both MT and IT cells lowered cell proliferation and cell invasion abilities, and thus increased the survival time of mice xenografted with tumor cells. This study suggested that the knockdown of miR-30 decreased proliferation and invasion of carcinoma cells, giving rise to the potential of miR-30 as a tumor target or marker candidate for breast cancer therapy.
Insights
MicroRNA-30 (miR-30) is elevated in invasive breast cancer cells. Reducing miR-30 levels inhibits cancer cell proliferation and invasion, suggesting miR-30 as a potential therapeutic target for breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer progression and metastasis mechanisms require further elucidation.
- Understanding molecular drivers is key to improving treatment outcomes for this lethal disease.
Purpose of the Study:
- To investigate the role of microRNAs, specifically miR-30, in breast cancer metastasis and recurrence.
- To evaluate the therapeutic potential of targeting miR-30 in breast cancer.
Main Methods:
- MCF-7 breast cancer cells were xenografted into mice.
- Tumor and adjacent normal tissues were cultured into mass tumor (MT) and invasive tumor (IT) cells.
- Microarray analysis identified microRNA expression differences.
- miR-30 knockdown was performed to assess its functional impact.
Main Results:
- Relative miR-30 levels were significantly higher in invasive tumor (IT) cells compared to mass tumor (MT) cells.
- Knockdown of miR-30 reduced both proliferation and invasion capabilities of breast cancer cells.
- Reducing miR-30 levels increased the survival time of tumor-bearing mice.
Conclusions:
- miR-30 plays a significant role in promoting breast cancer cell proliferation and invasion.
- Targeting miR-30 demonstrates potential for reducing tumor aggression.
- miR-30 is a promising candidate for a breast cancer therapeutic target or diagnostic marker.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:39Receptor-mediated Endocytosis
01:40Cell-mediated Immune Responses
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...